Oncotelic

Oncotelic

Biotechnology, 701 Gtwy BLVD Ste 210, Agoura Hills, California, 94080, United States, 11-50 Employees

oncotelic.com

  • facebook
  • twitter
  • LinkedIn

Who is ONCOTELIC

Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for...

Read More

map
  • 701 Gtwy BLVD Ste 210, Agoura Hills, California, 94080, United States Headquarters: 701 Gtwy BLVD Ste 210, Agoura Hills, California, 94080, United States
  • 1988 Date Founded: 1988
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ONCOTELIC

Oncotelic Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Oncotelic

Answer: Oncotelic's headquarters are located at 701 Gtwy BLVD Ste 210, Agoura Hills, California, 94080, United States

Answer: Oncotelic's official website is https://oncotelic.com

Answer: Oncotelic's revenue is $1 Million to $5 Million

Answer: Oncotelic's SIC: 2836

Answer: Oncotelic's NAICS: 325414

Answer: Oncotelic has 11-50 employees

Answer: Oncotelic is in Biotechnology

Answer: Oncotelic contact info: Phone number: Website: https://oncotelic.com

Answer: Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for cancer, covid-19, and other viruses

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access